BMJ Best Practice

参考文献

关键文献

Franz KB. A functional biological marker is needed for diagnosing magnesium deficiency. J Am Coll Nutr. 2004;23:738S-741S.

Shils ME. Magnesium. In: Shils ME, Olson JA, Shike M, et al., eds. Modern nutrition in health and disease. 9th ed. New York, NY: Lippincott Williams & Wilkins; 1999:169-192.

Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf. 2005;28:763-788.

Romani AM. Magnesium homeostasis and alcohol consumption. Magnes Res. 2008;21:197-204.

Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20:3-17.

参考文章

1.  Franz KB. A functional biological marker is needed for diagnosing magnesium deficiency. J Am Coll Nutr. 2004;23:738S-741S.

2.  Shils ME. Magnesium. In: Shils ME, Olson JA, Shike M, et al., eds. Modern nutrition in health and disease. 9th ed. New York, NY: Lippincott Williams & Wilkins; 1999:169-192.

3.  Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002;31:166-170.

4.  Nadler MJ, Hermosura MC, Inabe K, et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature. 2001;411:590-595.

5.  Wester PO. Magnesium. Am J Clin Nutr. 1987;45(5 Suppl):1305-1312.

6.  Groenestege WM, Hoenderop JG, van den Heuvel L, et al. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol. 2006;17:1035-1043.

7.  Cao G, Hoenderop JG, Bindels RJ. Insight into the molecular regulation of the epithelial magnesium channel TRPM6. Curr Opin Nephrol Hypertens. 2008;17:373-378.

8.  Quamme GA, de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Front Biosci. 2000;5:D694-D711.

9.  Romani AM, Scarpa A. Regulation of cellular magnesium. Front Biosci. 2000;5:D720-D734.

10.  Gunther T. Functional compartmentation of intracellular magnesium. Magnesium. 1986;5:53-59.

11.  Romani A, Scarpa A. Regulation of cell magnesium. Arch Biochem Biophys. 1992;298:1-12.

12.  Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf. 2005;28:763-788.

13.  Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf). 2008;69:338-341.

14.  Lameris AL, Hess MW, van Krujisbergen I, et al. Omeprazole enhances the colonic expression of the Mg2+ transporter TRPM6. Pflugers Arch. 2013;465:1613-1620.

15.  US Food and Drug Administration. FDA drug safety communication: low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs). March 2011. https://www.fda.gov/ (last accessed 29 August 2017).

16.  Belani CP, Schreeder MT, Steis RG, et al. Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study. Cancer. 2008;113:2512-2517.

17.  Barton CH, Vaziri ND, Martin DC, et al. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med. 1987;83:693-699.

18.  Romani AM. Magnesium homeostasis and alcohol consumption. Magnes Res. 2008;21:197-204.

19.  Wolf FI, Cittadini AR, Maier JA. Magnesium and tumors: ally or foe? Cancer Treat Rev. 2009;35:378-382.

20.  Pironi L, Malucelli E, Guidetti M, et al. The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure. Magnes Res. 2009;22:37-43.

21.  James MF, Cork RC, Harlen GM, et al. Interactions of adrenaline and magnesium on the cardiovascular system of the baboon. Magnesium. 1988;7:37-43.

22.  Hampson G, Konrad MA, Scoble J. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene. BMC Nephrol. 2008;9:12.

23.  Sha Q, Pearson W, Burcea LC, et al. Human FXYD2 G41R mutation responsible for renal hypomagnesemia behaves as an inward-rectifying cation channel. Am J Physiol Renal Physiol. 2008;295:F91-F99.

24.  Nijenhuis T, Vallon V, van der Kemp AW, et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115:1651-1658.

25.  Naderi AS, Reilly RF Jr. Hereditary etiologies of hypomagnesemia. Nature Clin Pract Nephrol. 2008;4:80-89.

26.  Vezzoli G, Soldati L, Gambaro G. Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport. Curr Pharm Biotechnol. 2009;10:302-310.

27.  Sukonpan K, Phupong V. Serum calcium and serum magnesium in normal and preeclamptic pregnancy. Arch Gynecol Obstet. 2005;273:12-16.

28.  Kisters K, Niedner W, Fafera I, et al. Plasma and intracellular Mg2+ concentrations in pre-eclampsia. J Hypertens. 1990;8:303-306.

29.  Kaufman ES. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm 2009;6(8 suppl):S51-S55.

30.  Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20:3-17.

31.  Rob PM, Dick K, Bley N, et al. Can one really measure magnesium deficiency using the short-term magnesium loading test? J Intern Med. 1999;246:373-378.

32.  Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10:1616-1622.

使用此内容应接受我们的免责声明